[Plasma insulin levels in endocrine diseases. 4. Effects of adrenergic receptor agents on plasma insulin levels].
D000293:Adolescent; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D001120:Arginine / Q000494:pharmacology; D003864:Depression, Chemical; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood*; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008729:Methoxamine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011941:Receptors, Adrenergic; D013268:Stimulation, Chemical; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*; D014044:Tolbutamide / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D007328:Insulin; D011941:Receptors, Adrenergic; D013565:Sympatholytics; D013566:Sympathomimetics; D010643:Phenoxybenzamine; D010656:Phenylephrine; D001120:Arginine; D014044:Tolbutamide; D011433:Propranolol; D008729:Methoxamine; D007545:Isoproterenol; D004837:Epinephrine; D010646:Phentolamine